ACM
MIRM icon

Aster Capital Management’s Mirum Pharmaceuticals MIRM Stock Holding History

Aster Capital Management’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-131
Closed -$5.9K – 1101
2026
Q1 		$5.9K Buy
+131
New +$12.3K ﹤0.01% 666
2025
Q4 		– Sell
-71
Closed -$5.21K – 1297
2025
Q3 		$5.21K Buy
+71
New +$4.51K ﹤0.01% 804
2025
Q2 		– Sell
-694
Closed -$33K – 1367
2025
Q1 		$33K Buy
694
+610
+726% +$28.8K 0.01% 903
2024
Q4 		$3.47K Sell
84
-181
-68% -$7.54K ﹤0.01% 907
2024
Q3 		$10.3K Buy
+265
New +$10.6K ﹤0.01% 801

Other funds holding MIRM

FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Aster Capital Management's MIRM Position: Q2 2026 in Review

Aster Capital Management sold out of Mirum Pharmaceuticals (MIRM) in Q2 2026, closing a stake of 131 shares — an estimated $5.9K sold.

Aster Capital Management first reported a position in MIRM in Q3 2024 and held it in 5 quarters. The position peaked at $33K in Q1 2025. 327 funds tracked by Wall St. Rank hold MIRM as of Q2 2026.

  • Aster Capital Management reported no remaining Mirum Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Aster Capital Management sold 131 Mirum Pharmaceuticals shares in Q2 2026, an estimated $5.9K.
  • Aster Capital Management first reported a position in Mirum Pharmaceuticals in Q3 2024 and held it in 5 quarters.
  • Aster Capital Management's Mirum Pharmaceuticals position peaked at $33K in Q1 2025.
  • 327 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q2 2026.

Based on Aster Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.